Cargando…

Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness

The objective of this study was to assess long-term use, adherence and efficacy of injectable disease modifying agents (DMAs). Multiple Sclerosis (MS) patients diagnosed during 2002-2010 with early treatment start and at least one year in first choice medication were included in a large university d...

Descripción completa

Detalles Bibliográficos
Autores principales: Järvinen, Elina, Holmberg, Markus, Sumelahti, Marja-Liisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066104/
https://www.ncbi.nlm.nih.gov/pubmed/27761226
http://dx.doi.org/10.4081/ni.2016.6513